home All News open_in_new Full Article

Gene therapy maker Sarepta tells FDA it won't halt shipments despite patient deaths

Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene therapy


today 3 w. ago attach_file Events

attach_file Economics
attach_file Events
attach_file Events
attach_file Events
attach_file Politics
attach_file Events
attach_file Events


ID: 1536001467
Add Watch Country

arrow_drop_down